A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1994
12/08/1994	CA2162855A1 Expression of urokinase plasminogen activator inhibitors
12/08/1994	CA2162726A1 Modified factor vii
12/08/1994	CA2162610A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock
12/07/1994	EP0626857A1 Improved peritoneal dialysis solutions with polypeptides
12/07/1994	EP0605690A4 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids.
12/07/1994	CN1096034A Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them
12/06/1994	US5371072 Asp-Pro-Arg α-keto-amide enzyme inhibitors
12/06/1994	US5371071 Peptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascade
12/06/1994	US5371007 Precipitation; controlling proteolytic enzyme activity
12/01/1994	DE4323754C1 New bifunctional urokinase derivs and related plasmids
11/1994
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0625987A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
11/30/1994	EP0625908A1 Antidote for hirudin and synthetic thrombin inhibitors
11/30/1994	EP0594725A4 Yolk sac stem cells.
11/30/1994	EP0574545B1 Phenyl amidines derivatives useful as platelet aggregation inhibitors
11/30/1994	EP0531410B1 (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol
11/29/1994	US5369020 Method for suppressing coloring of human serum albumin
11/24/1994	WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/24/1994	WO1994026892A1 Bmp-11 compositions
11/24/1994	WO1994026777A1 Thrombin inhibitors
11/24/1994	WO1994026760A1 SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
11/24/1994	WO1994026745A1 Fibrinogen receptor antagonists
11/24/1994	WO1994026732A1 Carbostyril derivatives
11/24/1994	WO1994026286A1 Oxygen-reduced aqueous solution of factor viii
11/24/1994	CA2162478A1 Sialyl lex analogues as inhibitors of cellular adhesion
11/24/1994	CA2161787A1 Fibrinogen receptor antagonists
11/24/1994	CA2139332A1 Carbostyril derivatives
11/23/1994	EP0625199A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium
11/23/1994	EP0625166A1 Sulphated polysaccharides, preparation thereof, pharmaceutical composition and use thereof.
11/23/1994	EP0625164A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
11/23/1994	EP0625051A1 Hepatic growth factor receptor
11/22/1994	US5367081 Vasodilator, antiallergen
11/22/1994	US5367059 Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor
11/22/1994	US5366973 Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyridazine pyrazolo[1,2]pyridazine, pyridazol[1,2-a][1,2]diazepine and pyrazolol[1,2-a][1,2]diazepine
11/22/1994	US5366967 Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
11/22/1994	US5366886 Human tissue plasminogen activator variant
11/17/1994	EP0624588A1 New quinoline derivatives with pharmacological activity
11/17/1994	EP0624584A1 Piperazine derivatives useful as calmodolin inhibitors
11/17/1994	EP0624375A2 Pharmaceutical compositions containing hirudin
11/17/1994	EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides
11/17/1994	EP0624199A1 Methods for producing thrombin
11/17/1994	EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy
11/17/1994	EP0624159A1 Pyridyl substituted imidazoles
11/17/1994	EP0624095A1 Methods and compositions for reducing blood loss
11/17/1994	EP0563280B1 Tissue plasminogen activator substitution variant
11/15/1994	US5364932 Pasteurizable, freeze-driable hemoglobin-based blood substitute
11/15/1994	US5364771 Genetic engineering
11/10/1994	WO1994025588A2 ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β)
11/10/1994	WO1994025582A1 Method of enhancing thrombolysis
11/10/1994	WO1994025571A1 Human erythroid progenitor cell population
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025055A1 Erythropoietin analog compositions and methods
11/10/1994	WO1994025051A1 Thrombin inhibitors
11/10/1994	WO1994025049A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025000A1 Hookworm anticoagulant
11/10/1994	CA2161796A1 Hookworm anticoagulant
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161651A1 Erythropoietin analog compositions and methods
11/10/1994	CA2161216A1 Amidino and guanidino substituted boronic acid inhibitors of tryspin-like enzymes
11/10/1994	CA2160871A1 Human erythroid progenitor cell population
11/10/1994	CA2159834A1 Thrombin inhibitors
11/10/1994	CA2159508A1 Method of enhancing thrombolysis
11/09/1994	EP0623629A1 Purified heparin fractions, process for obtaining them and pharmaceutical compositions containing the same
11/09/1994	EP0623615A1 Adhesion-receptor antagonists
11/09/1994	EP0623596A1 N-acylpyrrolidines or N-acylpiperidines having a guanidinyl- or amidinyl-substituted side chain as thrombin inhibitors
11/09/1994	EP0623595A1 Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
11/09/1994	EP0623143A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
11/09/1994	EP0623133A1 Substituted amino alkyl compounds
11/09/1994	EP0623126A1 Imidazole derivatives and their use as cytokine inhibitors
11/09/1994	EP0623120A1 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
11/09/1994	EP0576612A4 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
11/09/1994	EP0517756B1 Tissue plaminogen activator having fibrin specific properties
11/09/1994	EP0420937B1 Therapeutic compositions for the treatment of myocardial infarction
11/09/1994	CN1094718A Bicyclic fibrinogen antagonists
11/09/1994	CN1094577A Magnetotherapeutic food and preparing process thereof
11/08/1994	US5362915 Inhibitors of enzymes/hydrolases; antiallergens, antiinflammatory agents
11/08/1994	US5362902 Diuretics and treatment of cardiovascular disorders
11/08/1994	US5362858 Polyethylene glycol-hirudin conjugates, process for preparing them and their use for the treatment of thromboses
11/08/1994	US5362757 Administering for treatment of cardiovascular disorders while reducing side effects
11/08/1994	US5362716 Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
11/08/1994	CA2123057A1 Quinoline derivatives with pharmacological activity
11/04/1994	CA2122646A1 Guanidinyl- or amidinyl-substituted methylamino heterocyclic thrombin inhibitors
11/04/1994	CA2122397A1 Guanidinyl- or amidinyl-substituted heterocyclic thrombin inhibitors
11/03/1994	DE4342132C1 Process for the preparation of virus-inactivated vitamin K-dependent plasma components, and protein C and protein S-containing compositions by membrane chromatography
11/02/1994	EP0622372A1 New compound, leustroducsin H, its preparation and its therapeutic use
11/02/1994	EP0621789A1 Pharmaceutical pentapeptide compositions and methods of use thereof
11/02/1994	EP0621788A1 Hemoregulatory peptides
11/02/1994	EP0621784A1 An iron-containing composition for the prevention of anaemia and a method for producing the composition.
11/02/1994	CN1094446A ECK receptor ligands
11/01/1994	CA1332838C 4-alkyl-1,4-dihydropyridines with paf-acether-antagonist activity
11/01/1994	CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/27/1994	WO1994024298A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound
10/27/1994	WO1994024156A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications
10/27/1994	WO1994024125A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
10/27/1994	WO1994023709A1 Production of recombinant factor xa inhibitor of leech hirudo medicinalis
10/27/1994	CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo
10/27/1994	CA2160537A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical prophylactic and diagnostic applications
10/27/1994	CA2160020A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands
10/26/1994	EP0621285A1 Novel megakaryocyte amplifier

1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 671